4. Electrolyte and Cardiovascular Medication Effects

Key Takeaways

  • Hyperkalemia can produce narrow peaked T waves, loss of visible P waves, a wide QRS or a sine-wave pattern. Findings vary and do not follow a required order.

  • Flattened T waves, ST depression and prominent U waves can accompany hypokalemia. Labs and clinical context determine the cause.

  • High calcium can shorten the ST and QT intervals; low calcium can prolong them. Low magnesium increases susceptibility to torsades.

  • Some medications slow the rate or AV conduction. Others change potassium or prolong QTc. Document the specific drug and timing.

  • Therapeutic digoxin can cause scooped ST depression or a longer PR. Compare the baseline and report new symptoms or rhythm changes; morphology alone does not establish toxicity or exclude ischemia.

Last updated: November 2026

The AMCA blueprint includes common cardiovascular drug classes and effects. Record the available medication history and use it to describe related ECG changes accurately. Assess urgent findings promptly even when the medication history or lab values are incomplete.

Potassium and ECG Changes

Hyperkalemia can produce tall, narrow, tented T waves. With more severe conduction effects, P waves may flatten or disappear, the PR may lengthen, and the QRS may widen. In extreme cases the QRS and T wave merge into a sine-wave pattern. Changes may overlap, occur in a different order or be absent. An ECG cannot reliably estimate the serum potassium or exclude hyperkalemia.

Escalate a new wide or sine-wave pattern with suspected hyperkalemia immediately and assess the patient. Kidney dysfunction is relevant context. Give the clinician the observable changes and any known laboratory results without waiting for confirmation to report an urgent tracing.

Hypokalemia can occur with potassium-wasting diuretics, vomiting or diarrhea. Look for flattening of T, ST depression and prominent U waves. Low potassium increases susceptibility to ventricular arrhythmias, including torsades, and predisposes to digoxin toxicity. Identify the waveform and report it alongside the history.

Calcium and Magnesium: The Interval Setters

Calcium changes can affect the ST segment and therefore the QT. High calcium can shorten both; low calcium can prolong them. Hypomagnesemia is a risk factor for torsades and has no single diagnostic ECG signature.

Electrolyte changePossible tracing cluesWhat to report
HyperkalemiaPeaked T waves, attenuated P waves, longer PR, wide QRS or sine-wave patternPrompt urgent escalation for an alarming new pattern
HypokalemiaFlat T waves, ST depression, prominent U wavesNew morphology, ectopy and symptoms
HypercalcemiaShorter QT, often from a shorter STInterval, context and symptoms
HypocalcemiaLonger QT, often from a longer STInterval, context and symptoms
HypomagnesemiaIncreased torsades susceptibility, especially with other risk factorsKnown lab result with rhythm changes and symptoms

Cardiovascular Medication Classes: What the Technician Documents and Sees

ClassTypical examplesRecognition on the tracing
Beta-blockersmetoprolol, atenololSlower sinus rate; slower AV conduction with a longer PR; watch for marked bradycardia or new block
Calcium channel blockers (rate-controlling)diltiazem, verapamilSimilar slowing of rate and AV conduction
ACE inhibitors and ARBslisinopril, losartanCan increase serum potassium; correlate new ECG changes with history and labs
Diureticsfurosemide, hydrochlorothiazideLoop and thiazide agents can lower potassium; potassium-sparing agents can raise it
DigoxindigoxinCan slow ventricular response in AF; therapeutic use can depress ST and prolong PR
QT-prolonging drugssome antibiotics, some antipsychotics, some antiarrhythmicsProlonged QTc — the torsades setup; flag prolonged QTc findings

Beta-Blockers and Rate-Controlling Calcium Channel Blockers

Beta-blockers and rate-controlling calcium channel blockers such as diltiazem or verapamil can slow the sinus rate and AV conduction. Report a new or symptomatic low rate, prolonged PR or dropped beats. Include the drug and timing if known, without assuming the medication caused the finding.

ACE Inhibitors, ARBs, and Diuretics: The Potassium Movers

ACE inhibitors and ARBs can increase potassium, especially with kidney dysfunction or other potassium-raising drugs. Loop and thiazide diuretics can lower potassium and magnesium. Potassium-sparing drugs such as spironolactone can increase potassium. For example, report new U-wave prominence in a patient taking furosemide along with any recorded symptoms and dose timing. The clinician can correlate it with a serum result.

Digoxin: Effect Versus Toxicity

Therapeutic digoxin can cause scooped ST depression and PR prolongation. Document use and compare with an earlier ECG when available. The scooped shape alone neither demonstrates toxicity nor rules out ischemia.

Report possible toxicity signs such as nausea, vomiting, appetite loss, visual disturbances or a new rhythm change. Frequent ventricular ectopy, bradycardia, new AV block or atrial tachycardia with block can occur with toxicity. Low potassium increases susceptibility. Report symptoms and changes promptly and leave the medication decision to the clinician.

QT-Prolonging Drugs and the Prolonged-QTc Flag

A prolonged QTc can indicate delayed ventricular repolarization. Some agents, including azithromycin, citalopram and sotalol, can raise torsades risk. Obtain the comparison tracing and document how the value was measured or whether it was machine flagged. An adult hospital QTc above 500 ms or a substantial increase from the patient’s baseline calls for prompt clinical review under the monitoring protocol. Rate correction, a wide QRS, or an unclear T-wave end can affect the value.

Nitrates and Symptom Timing

Nitroglycerin can relieve angina. Document when an ordered medication was given if this is known and when symptoms or ECG changes occurred. Symptom relief alone does not establish a cause.

Scope Check

Record the medications you can verify, the time of the tracing, the change observed and the patient’s symptoms. For a new urgent pattern, assess and notify promptly. Medication adjustment and diagnosis belong to the clinician.

Test Your Knowledge

A patient with kidney failure has new peaked, tented T waves, no visible P waves and a widened QRS of 0.16 seconds. Which electrolyte disturbance is most consistent with this presentation?

A

Hypocalcemia

B

Hypokalemia

C

Hypercalcemia

D

Hyperkalemia

Test Your Knowledge

A patient taking digoxin has unchanged smooth scooped ST depression compared with a prior tracing, with no new symptoms or arrhythmia. How should the technician describe it?

A

A pattern compatible with therapeutic digoxin effect; document the comparison and medication

B

Definite toxicity requiring the technician to stop the drug

C

Proof of acute inferior infarction

D

An indication to repeat the tracing until ST segments normalize

Test Your Knowledge

A monitored adult has a new machine-flagged QTc of 0.52 seconds after starting azithromycin. Why should the technician report it promptly?

A

Azithromycin always slows the sinus rate

B

0.52 seconds indicates a shortened QTc

C

520 ms is markedly prolonged in hospital monitoring, and the drug can increase torsades risk

D

The finding matters only if the patient also takes digoxin

Sections you finish are checked off in the contents.

Congratulations!

You've completed this section

Continue exploring other exams